| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7504492 | Drug and Alcohol Dependence | 2015 | 6 Pages |
Abstract
Our findings suggest that buprenorphine administered to non-opioid-tolerant adults should be started at a lower, individualized dose than customarily used for adults actively using opioids, and that non-opioid-tolerant pre-release prisoners can be successfully inducted onto therapeutic doses prior to release.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Frank J. Vocci, Robert P. Schwartz, Monique E. Wilson, Michael S. Gordon, Timothy W. Kinlock, Terrence T. Fitzgerald, Kevin E. O'Grady, Jerome H. Jaffe,